You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MR 4.5

Showing 1926 - 1950 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes Trial in Exeter (Sitagliptin - DPP4i, Canagliflozin - SGLT2i, Pioglitazone - TZD)

Completed
  • Type 2 Diabetes
  • Sitagliptin - DPP4i
  • +2 more
  • Exeter, United Kingdom
    Exeter Clinical Research Facility
Mar 30, 2021

Clinical Applicantion of Multi-Tracer PET/MR Imaging in

Recruiting
  • Alzheimer Disease
  • +3 more
  • PET/MR
  • Beijing, Beijing, China
    Xuanwu hospital
Oct 18, 2023

Brain Substrates in Adults With Obesity

Completed
  • Anhedonia
  • Obesity
    • Mississauga, Ontario, Canada
      Canadian Rapid Treatment Centre of Excellence
    Jul 27, 2021

    The Designer D-dimer Deep Vein Thrombosis Diagnosis (4D) Study

    Completed
    • Suspected Deep Vein Thrombosis
      • Edmonton, Alberta, Canada
      • +9 more
      Sep 27, 2021

      COPD (COPD) Trial in Worldwide (BGF MDI HFO 320/14.4/9.6 µg, BGF MDI HFA 320/14.4/9.6 µg)

      Recruiting
      • Chronic Obstructive Pulmonary Disease (COPD)
      • BGF MDI HFO 320/14.4/9.6 μg
      • BGF MDI HFA 320/14.4/9.6 μg
      • Phoenix, Arizona
      • +96 more
      Jan 23, 2023

      Esophagus Cancer, Esophagogastric Junction Cancer, Chemoradiation Trial in China (Radiotherapy, Platinum based chemo, Paclitaxel

      Recruiting
      • Esophagus Cancer
      • +5 more
      • Radiotherapy
      • +5 more
      • Anyang, Henan, China
      • +4 more
      Aug 17, 2022

      Nicotine Dependence, Nicotine Dependence, Cigarettes, Tobacco Use Trial in Overland Park (Virginia Tobacco flavored JUUL 5%

      Completed
      • Nicotine Dependence
      • +3 more
      • Virginia Tobacco flavored JUUL 5% ENDS
      • +6 more
      • Overland Park, Kansas
        Vince & Associates Clinical Research
      Jun 10, 2021

      Chronic Myelogenous Leukemia - Chronic Phase Trial (asciminib)

      Recruiting
      • Chronic Myelogenous Leukemia - Chronic Phase
      • Birmingham, Alabama
      • +25 more
      Jan 10, 2023

      Post Stroke Psychological Distress

      Active, not recruiting
      • Stroke
        • Berlin, Germany
          Charité, Campus Benjamin Franklin, Dep. of Neurology
        Aug 27, 2022

        Metastatic Renal Cell Carcinoma Trial in Canada, United States (AGS-16C3F, Axitinib)

        Completed
        Has Results
        • Metastatic Renal Cell Carcinoma
        • Tucson, Arizona
        • +25 more
        Nov 9, 2021

        NSCLC, Advanced Pancreatic Adenocarcinoma, Unresectable Pancreatic Cancer Trial in Boston (AGuIX, Radiotherapy)

        Recruiting
        • Non-small Cell Lung Cancer
        • +3 more
        • Boston, Massachusetts
        • +1 more
        Oct 25, 2021

        Asthma Trial in Worldwide (Tezepelumab (APFS), Tezepelumab (AI))

        Completed
        Has Results
        • Asthma
        • Tezepelumab (APFS)
        • Tezepelumab (AI)
        • Hoover, Alabama
        • +35 more
        Jul 9, 2021

        Accurate Point of Care Liver Disease Diagnostics

        Recruiting
        • NAFLD
        • Nonalcoholic Fatty Liver
        • Liverscope® exam
        • +5 more
        • La Jolla, California
          University of California San Diego
        Aug 8, 2023

        Coronary Artery Disease, Aortic Valve Stenosis, Extracorporeal Circulation; Complications Trial in Worldwide (Minimal Invasive

        Recruiting
        • Coronary Artery Disease
        • +2 more
        • Minimal Invasive Extracorporeal Circulation
        • Conventional cardiopulmonary bypass
        • Toronto, Canada
        • +12 more
        Aug 4, 2022

        Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in United States

        Active, not recruiting
        • Castration-Resistant Prostate Carcinoma
        • +2 more
        • Duarte, California
        • +22 more
        Jan 3, 2023

        Metabolic Syndrome Trial in Toronto (Exercise Training)

        Recruiting
        • Metabolic Syndrome
        • Exercise Training
        • Toronto, Ontario, Canada
          University Health Network - Toronto General Hospital
        Sep 27, 2021

        Acne Vulgaris Trial in Canada, United States (IDP-126 Gel, IDP-126 Vehicle Gel)

        Completed
        • Acne Vulgaris
        • IDP-126 Gel
        • IDP-126 Vehicle Gel
        • Rogers, Arkansas
        • +12 more
        Mar 15, 2022

        Acute Lymphoblastic Leukemia Trial in Canada, United States (ITMHA, Dexamethasone, Mitoxantrone)

        Active, not recruiting
        • Acute Lymphoblastic Leukemia
        • Los Angeles, California
        • +17 more
        Jun 6, 2022

        Leukemia, Myelodysplastic Syndrome, Recurrent Myelodysplastic Syndrome Trial in Houston (drug, biological, other)

        Recruiting
        • Leukemia
        • +2 more
        • Houston, Texas
          M D Anderson Cancer Center
        Jan 13, 2021

        Glioblastoma, Gliosarcoma, Supratentorial Glioblastoma Trial in Houston (Mefloquine, Memantine Hydrochloride, Metformin

        Active, not recruiting
        • Glioblastoma
        • +2 more
        • Houston, Texas
          M D Anderson Cancer Center
        Jun 16, 2021

        Hepatocellular Carcinoma Trial in Worldwide (Ramucirumab, Placebo)

        Completed
        Has Results
        • Hepatocellular Carcinoma
        • Daly City, California
        • +130 more
        Jan 5, 2022

        Mild Cognitive Impairment Trial in Thessaloniki (Cannabidiol Oil, Homotaurine)

        Recruiting
        • Mild Cognitive Impairment
        • Thessaloniki, Greece
          Greek Association of Alzheimer's Disease and Related Disorders
        Aug 25, 2021

        Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (olaparib, enzalutamide, abiraterone acetate)

        Active, not recruiting
        Has Results
        • Metastatic Castration-resistant Prostate Cancer
        • Anchorage, Alaska
        • +203 more
        Jan 27, 2023

        Paroxysmal Nocturnal Hemoglobinuria Trial in Leeds, London (Eculizumab, Ravulizumab)

        Active, not recruiting
        • Paroxysmal Nocturnal Hemoglobinuria
        • Eculizumab
        • Ravulizumab
        • Leeds, United Kingdom
        • +1 more
        Sep 21, 2021

        Hepatitis B, Chronic Trial in Worldwide (VIR-2218, VIR-3434, PEG-IFNa)

        Recruiting
        • Hepatitis B, Chronic
        • San Francisco, California
        • +39 more
        Oct 3, 2022